3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
35
Carcinoma, Non-Small-Cell Lung
27
Breast Neoplasms
15
Lung Neoplasms
13
Neoplasm Metastasis
12
Triple Negative Breast Neoplasms
11
Neoplasms
10
Colorectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Head and Neck Neoplasms
4
Carcinoma, Pancreatic Ductal
4
Stomach Neoplasms
3
Neoplasms by Site
3
Gastrointestinal Neoplasms
3
Carcinoma
3
Adenocarcinoma
3
Vaccinia
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplasms by Histologic Type
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thymoma
1
Interventions
durvalumab
1
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gallbladder Cancer Unresectable
×
130-nm albumin-bound paclitaxel
×
90 days
×
Clear all
NCT06591650
2026-05-14
GCND
Fudan University
Phase 2
Recruiting
33 enrolled